- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03520582
Placement of Novel Endoscopic Enteral Feeding Tube (LEGEND)
Placement of Novel Endoscopic Enteral Feeding Tube - A Feasibility Study
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Enteral feeding is the preferred route of nutrient delivery in hospitalized patients who cannot eat sufficiently. Placement of enteral feeding tubes carries a risk of misplacement especially in patients who are unable to fully collaborate during the tube placement due to neurological impairment and/or the presence of an artificial airway. The misplacement of a feeding tube in the airways has a high risk of severe complications, including pneumonia, mechanical damage of airways and the lung, and death. The verification of correct tube placement can be done using radiography, or interventions aimed at confirming the location of the tube tip by aspiration of gastric contents, and by auscultation during injection of air.
Approximately 20-25 % of patients treated in intensive care units are likely to need placement of a feeding tube, while undergoing mechanical ventilation and having an artificial airway. This high risk patient group would benefit from technologies allowing direct visualization of tube placement. It is also expected that direct visualization of tube placement will allow confirmation of tube placement and therefore eliminate the need of radiography (radiation).
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Bern, Suisse, 3010
- Universitätsklinik für Intensivmedizin
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
Healthy volunteers
- Informed Consent as documented by signature (Appendix Informed Consent Form)
- Age >18 years
Patients
- Age >18 years
- mechanically ventilated and requiring a placement of a postpyloric feeding tube on clinical indications
- Informed Consent as documented by signature of relatives
Exclusion Criteria:
Healthy volunteers and patients
- Unrepaired tracheoesophageal fistula
- history of prior esophageal or gastric surgery
- esophageal obstruction, stricture, varices or diverticulum
- esophageal or gastric perforation, gastric or esophageal bleeding
- recent oropharyngeal surgery
- cervical spine injury or anomaly
Additional exclusion criterion for patients only
• know severe coagulopathy (defined as thrombocyte count less than 30x10e9/l or International Normalized Ratio (INR) > 3)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: Cohorte
- Perspectives temporelles: Autre
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
---|---|
Volunteers
Cohort of 10 healthy subjects.
The tube will be placed and removed by a gastroenterologist experienced in performing endoscopic postpyloric tube placement.
Secondly, a second tube will be placed and removed.
|
Placement of enteral feeding tubes
|
Mechanically ventilated ICU
Cohort of 20 mechanically ventilated intensive care patients requiring a placement of a postpyloric feeding tube on clinical indications.
|
Placement of enteral feeding tubes
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Success rate of postpyloric placement, time to reach intragastric and postpyloric position, ease of insertion, handling and image quality.
Délai: During Intervention Visit, an average of 24 hours
|
using a visual analog scale of 1-10, with 1 indicating the best value
|
During Intervention Visit, an average of 24 hours
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
In healthy volunteers, time required to reach gastric and postpyloric placement
Délai: During Intervention Visit, an average of 24 hours
|
Questionnaire with various positions and the time to reach the position
|
During Intervention Visit, an average of 24 hours
|
In healthy volunteers, ease of insertion, handling, and image quality assessed
Délai: During Intervention Visit, an average of 24 hours
|
Using a visual analog scale of 1-10, with 1 indicating the best value
|
During Intervention Visit, an average of 24 hours
|
In healthy volunteers, Usability of specific features - tip steerability, lens rinsing and flushing, air insufflation and fluid extraction
Délai: During Intervention Visit, an average of 24 hours
|
Using a visual analog scale of 1-10, with 1 indicating the best value.
|
During Intervention Visit, an average of 24 hours
|
In patients: Necessity of use of additional sedation/analgesia for the procedure in addition to already established sedation in the context of mechanical ventilation.
Délai: During Intervention Visit, an average of 24 hours
|
Questionnaire Yes/No and a visual analog scale of 1-10, with 1 indicating the best value
|
During Intervention Visit, an average of 24 hours
|
In patients: Ease of insertion, handling, and image quality assessed using a visual analog scale of 1-10, with 1 indicating the best value.
Délai: During Intervention Visit, an average of 24 hours
|
using a visual analog scale of 1-10, with 1 indicating the best value
|
During Intervention Visit, an average of 24 hours
|
In patients: Usability of specific features - tip steerability, lens rinsing and flushing, air insufflation and fluid extraction.
Délai: During Intervention Visit, an average of 24 hours
|
using a visual analog scale of 1-10, with 1 indicating the best value
|
During Intervention Visit, an average of 24 hours
|
In patients: Subjective global assessment of the intensivist on whether or not the technique is suitable for clinical use in patients.
Délai: During Intervention Visit, an average of 24 hours
|
using a visual analog scale of 1-10, with 1 indicating the best value
|
During Intervention Visit, an average of 24 hours
|
In patients: Time required to reach gastric and postpyloric placement
Délai: During Intervention Visit, an average of 24 hours
|
Questionnaire
|
During Intervention Visit, an average of 24 hours
|
In patients: Feasibility of the feeding through Veritract tube.
Délai: During Intervention Visit, an average of 24 hours
|
using a visual analog scale of 1-10, with 1 indicating the best value
|
During Intervention Visit, an average of 24 hours
|
Bleeding and infection related to tube placement
Délai: During Intervention Visit, an average of 24 hours
|
AE/SAE Questionnaire Yes/No
|
During Intervention Visit, an average of 24 hours
|
Erroneous placement in larynx and trachea and associated complications (pneumothorax).
Délai: During Intervention Visit, an average of 24 hours
|
Outcome mesured with a questionnaire Yes/No
|
During Intervention Visit, an average of 24 hours
|
Injuries of the oesophagus, stomach or small intestine related to tube placement.
Délai: During Intervention Visit, an average of 24 hours
|
Outcome mesured with a questionnaire Yes/No
|
During Intervention Visit, an average of 24 hours
|
Reflux of stomach contents during tube placement
Délai: During Intervention Visit, an average of 24 hours
|
AE/SAE Questionnaire Yes/No
|
During Intervention Visit, an average of 24 hours
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Tobias Merz, Dr. med., Inselspital Bern, Universitätsklinik für Intensivmedizin
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 16.22.CLI
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Volontaires en bonne santé
-
AstraZenecaParexelComplété
Essais cliniques sur Tube placement
-
Kyungpook National University HospitalComplétéPression du brassardCorée, République de
-
Wakayama Medical UniversityComplétéCancer du pancréas | Cancer des voies biliaires | Pancréatite | Cancer duodénal | Cancer ampullaireJapon
-
Kyungpook National University HospitalComplétéPression du brassardCorée, République de
-
Karaman Training and Research HospitalComplété
-
Phoenix Children's HospitalRecrutementAtrésie de l'œsophage | Fistule trachéo-oesophagienneÉtats-Unis
-
LunGuard Ltd.Inconnue
-
University Hospital, MontpellierCBS; MICALISRecrutementCancer | ProstateFrance
-
Assiut UniversityInconnueHémothorax ; TraumatiqueEgypte
-
The First Affiliated Hospital of Soochow UniversityComplété
-
University of Texas Southwestern Medical CenterComplétéVentilation pulmonaire unique | Tube endotrachéal à double lumièreÉtats-Unis